IFN-γ acts as anti-angiogenic cytokine in the human cornea by regulating the expression of VEGF-A and sVEGF-R1
- 26 September 2008
- journal article
- research article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 374 (3), 479-484
- https://doi.org/10.1016/j.bbrc.2008.07.042
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Inhibition of corneal neovascularization by recombinant adenovirus-mediated sFlk-1 expressionBiochemical and Biophysical Research Communications, 2007
- Dexamethasone Inhibits Interleukin-1β-Induced Corneal Neovascularization: Role of Nuclear Factor-κB-Activated Stromal Cells in Inflammatory AngiogenesisThe American Journal of Pathology, 2007
- Transforming growth factor‐β induces expression of vascular endothelial growth factor in human retinal pigment epithelial cells: Involvement of mitogen‐activated protein kinasesJournal of Cellular Physiology, 2003
- Synthesis and Activity of New Aryl- and Heteroaryl-Substituted Pyrazole Inhibitors of the Transforming Growth Factor-β Type I Receptor Kinase DomainJournal of Medicinal Chemistry, 2003
- The biology of VEGF and its receptorsNature Medicine, 2003
- Photochemical preparation of a pyridone containing tetracycle: A jak protein kinase inhibitorBioorganic & Medicinal Chemistry Letters, 2002
- Inhibition of Angiogenesis by Adenovirus-Mediated sFlt-1 Expression in a Rat Model of Corneal NeovascularizationHuman Gene Therapy, 2001
- Blockade of TGF-β by in vivo gene transfer of a soluble TGF-β type II receptor in the muscle inhibits corneal opacification, edema and angiogenesisGene Therapy, 2000
- Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas.2000
- Immunohistochemical Localization of Vascular Endothelial Growth Factor, Transforming Growth Factor α, and Transforming Growth Factor β1 in Human Corneas with NeovascularizationCornea, 2000